Obesity Drug Boom, Split Make This Stock a Heavy Bargain

Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

→ Invest before this deal closes on 9/18 (From Deal Maker) (Ad)

Should you invest $1,000 in Novo Nordisk A/S right now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Companies Mentioned in This Article

Company	MarketRank™	Current Price	Price Change	Dividend Yield	P/E Ratio	Consensus Rating	Consensus Price Target
Novo Nordisk A/S (NVO)	2.0673 of 5 stars 2.07 / 5 stars	$136.81	+1.2%	0.53%	47.18	Moderate Buy	$145.17
Eli Lilly and Company (LLY)	4.6524 of 5 stars 4.65 / 5 stars	$936.41	+1.7%	0.56%	137.91	Moderate Buy	$961.76
Walmart (WMT)	4.4795 of 5 stars 4.48 / 5 stars	$79.83	+1.3%	1.04%	34.16	Moderate Buy	$78.99
Mondelez International (MDLZ)	3.948 of 5 stars 3.95 / 5 stars	$74.39	+0.1%	2.53%	23.62	Buy	$78.61
Nestlé (NSRGY)	0.6254 of 5 stars 0.63 / 5 stars	$103.43	-1.1%	2.04%	N/A	Reduce	N/A